Clinical Trials Logo

Filter by:
NCT ID: NCT02120404 Active, not recruiting - Septic Shock Clinical Trials

Pilot Phase II Study: Hemodynamic Tolerance and Anti-inflammatory Effects of Esmolol During the Treatment of Septic Shock

THANE
Start date: April 2015
Phase: Phase 2
Study type: Interventional

The purpose of this study is : - to evaluate the hemodynamic tolerance of esmolol titrated to obtain a lowering of heart rate of 10% or 20%.

NCT ID: NCT02120053 Active, not recruiting - Alveolar Bone Loss Clinical Trials

Interest of Bone Substitute Material in Immediate Complete Denture

PANORAMIX
Start date: October 2013
Phase: Phase 2/Phase 3
Study type: Interventional

More than 2 million French people suffer from the widespread disability of edentulism, with large consequences on function, nutrition, aesthetics and well-being. Complete denture is a common therapeutic strategy. The immediate complete denture technique consists in placing the denture in the same clinical session as last anterior teeth extractions. With this technique, aesthetic and function are immediately reintroduced and the patient is never left toothless or without any denture. After teeth extractions, alveolar healing process leads to ridge resorption with bone volume modifications and reduction in height and width. However ridge bone volume is an essential factor in removable denture stability. With implantology as an alternative prosthetic strategy, ridge volume is also a most important factor to place dental implants in a situation close to previous dental roots position. In order to preserve bone volume, a current alternative strategy proposes to place bone substitute materials in tooth sockets after extraction. This strategy was never evaluated with the immediate complete denture technique. Hypothesis: A new strategy associating immediate complete denture and bone substitute material is more effective than conventional immediate complete denture in a bone preservation perspective.

NCT ID: NCT02117375 Active, not recruiting - Multiple Sclerosis Clinical Trials

EMISEP : Early Spinal Cord Lesions and Late Disability in Relapsing Remitting Multiple Sclerosis Patients

EMISEP
Start date: January 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the prognostic value of early focal lesions and early diffuse lesions on ambulatory disability progression within 5 years after clinical onset.

NCT ID: NCT02116504 Active, not recruiting - Clinical trials for Rheumatoid Arthritis

Anti-Biopharmaceutical Immunization: Prediction and Analysis of Clinical Relevance to Minimize the Risk of Immunization in Rheumatoid Arthritis Patients or Juvenile Idiopathic Arthritis Patients

ABI-RA
Start date: April 2014
Phase: N/A
Study type: Interventional

One of the main potential causes of these failures of BP therapy response is the development of Anti-drug Anti-body (ADAb) in some patients. ADAb may decrease the efficacy of BPs by neutralizing them or modifying their clearance and they may be associated with BP-specific hypersensitivity reactions. The prediction, prevention and cure of anti-drug (AD) immunization are thus major goals in BP development. This prospective study (ABI-RA) will assess the occurrence of ADAb using standardized and validated assay(s) and also cellular, genetic and molecular parameters in RA/JIA patients treated with adalimumab, etanercept, infliximab and rituximab or tocilizumab, to address the mechanism of immunogenicity. Patient-related factors that might predispose an individual to an immune response will be taken into account: underlying disease, genetic background, immune status, including immunomodulating therapy and dosing schedule.

NCT ID: NCT02114034 Active, not recruiting - Severe Asthma Clinical Trials

Cohort Analysis of Clinical and Biological Severe Childhood Asthma

COBRAPed
Start date: November 12, 2013
Phase:
Study type: Observational

The purpose of this prospective study is: - to identify by cluster analysis the main phenotypes of severe asthma and factors involved in the severity, - to determine the clinical and functional outcomes, - to identify the factors associated with severe asthma from childhood to adulthood.

NCT ID: NCT02107703 Active, not recruiting - Breast Neoplasms Clinical Trials

A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer

MONARCH 2
Start date: July 22, 2014
Phase: Phase 3
Study type: Interventional

The main purpose of this study is to compare progression-free survival for women with hormone receptor positive (HR+), human epidermal growth factor receptor (HER2) negative advanced breast cancer receiving either abemaciclib + fulvestrant or fulvestrant alone. Participants will be randomized to abemaciclib or placebo in a 2:1 ratio. The study will last about 9 months for each participant. For the endocrine naïve cohort, all participants will received abemaciclib + fulvestrant.

NCT ID: NCT02107027 Active, not recruiting - Atrial Fibrillation Clinical Trials

Pulmonary Veins Circular Ablation Catheter Evaluation for Atrial Fibrillation

EVACIRC
Start date: March 2013
Phase: N/A
Study type: Interventional

The aim of this study is to compare two type of ablation catheters for pulmonary veins isolation (PVI) in subjects with atrial fibrillation. Currently, two technologies of irrigated ablation catheters are available for PVI. One of the two, the "conventional" catheter is widely used for atrial fibrillation (AF) treatment but has not been specifically created for pulmonary veins isolation, therefore, point by point encircling lesions are cumbersome and time consuming. The second is a new ablation catheter with a circular shape provided with 10 irrigated electrodes designed to create encircling lesions, necessary to obtain pulmonary veins isolation, could allow an easier and faster isolation compared to the conventional way. These two types of catheters have never been compared for atrial fibrillation. If one of the two catheters appears to be more efficient or causes fewer complications, the use of this catheter could be favored to conduct AF ablation.

NCT ID: NCT02106949 Active, not recruiting - Clinical trials for Patients Having Realized a Suicide Attempt

Short Message System (SMS) Monitoring Intended for the Suicidal Patients

Start date: August 2014
Phase: Phase 3
Study type: Interventional

The study wants to prove that SMS monitoring reduced the number of suicide attempts in six months according to the beginning of its implementation in the group of the patients benefiting SMS compared with the group of patients benefiting from the usual care.

NCT ID: NCT02101957 Active, not recruiting - Clinical trials for Huntington's Disease

Multicentric Trial of the Treatment of Huntington's Disease by Cysteamine (RP103)

Start date: October 2010
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to evaluate the effect of cysteamine in patients with symptomatic Huntington's disease by comparing two groups of patients (cysteamine vs placebo) on the results of the Unified Huntington's Disease Rating Scale (UHDRS, Huntington study group 1996).

NCT ID: NCT02100722 Active, not recruiting - Coronary Disease Clinical Trials

A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease

FAME 3
Start date: August 25, 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether Fractional flow reserve (FFR, (coronary pressure wire-based index for assessing the ischemic potential of a coronary lesion)-guided percutaneous coronary intervention (PCI) in patients with multivessel coronary artery disease (CAD) will result in similar outcomes to coronary artery bypass graft surgery (CABG).